Individuals Coming Off Anti-Obesity Jabs Put On Weight at a Quadrupled Rate Than Those on Conventional Diets

New research reveals that individuals who stop using blockbuster weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who halt conventional diet and exercise regimens.

Findings released in a leading health publication shows that while overweight people frequently drop about a fifth of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month once they quit.

"People buying such drugs must be aware of the danger of quick weight regain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.

This pace of regain means a reversion to pre-treatment weight within about 18 months.

Analyzing Therapies

The analysis, which looked at dozens of studies involving over 9,000 of patients, compared the effects of GLP-1 agonists with conventional dieting.

The team point out that individuals who lose weight through diet and exercise typically experience a more gradual weight regain—around 0.1 kg a month—post-intervention.

The Reason for the Rapid Rebound

Experts suggest the way of the jabs accounts for the accelerated rebound.

These medications copy a body's own chemical called GLP-1, which controls appetite.

"Artificially providing the hormone concentrations far above than normal might result in the body to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating much more probable."

An Ongoing Issue?

Health authorities advise the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.

A number of clinicians contend that, due to the significant potential of relapse, the treatment might need to be ongoing.

This view is supported by drug manufacturers, who note that the findings "emphasize the persistent nature of obesity," comparing it to managing diseases like high blood pressure.

User Testimonies

People who have discontinued the medication report a intense resurgence of appetite.

"It felt as if a switch that goes on and I was suddenly starving," recalled an individual.

This challenge is compounded if individuals have not established lasting lifestyle or habit modifications during treatment.

Widespread Interest

Survey data show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.

• Use is greater among women than men.
• The middle-aged age group shows the greatest usage rates.
• Many access the drugs through private healthcare rather than the NHS.

Ultimately, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a permanent fix and lasting health benefits hinges on integrated lifestyle management.